Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles M Zelen, DPM
Professional Education and Research Institute
Principal Investigator - David Armstrong, DPM, MD, PhD
USC / Salsa
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alan M Jacobs and Associates
St Louis, Missouri, United States
- Lower Extremity Institute of Research and Therapy
Youngstown, Ohio, United States
- Martinsville Research Institute
Martinsville, Virginia, United States
- Professional Education and Research Institute
Roanoke, Virginia, United States
- Shenandoah Lower Extremity Research Institute
Troutville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Dec 2017
- Primary completion
- 31 Oct 2018
- Completion
- 31 Oct 2018
- Last update posted
- 3 Aug 2022
- Registered enrollment
- 40
- Registry id
- NCT03398538
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.